Robert Blazej
Partner at Mission Biocapital
About
A biotechnologist and partner based in San Francisco with over 10 years of operational experience in life science companies and engineering. He co-founded Allopartis Biotechnologies, which was acquired by Novozymes in 2013, and holds a PhD in Bioengineering from UC San Francisco and Berkeley.
Investments
Board seats
Telo Therapeutics, Inc.
As listed on the firm's website.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital